Company page

Insilico Medicine Cayman Topco

Insilico Medicine Cayman Topco, trading under the ticker 3696 on the Hong Kong market, has a market capitalization of approximately HKD 2.8 billion. The company focuses on advancing drug discovery and development through artificial intelligence and machine learning technologies. Its innovative approach aims to enhance the efficiency and effectiveness of the pharmaceutical research process.